Extracellular Vesicle-mediated Crosstalk Between Pancreatic Cancer and Stromal Cells in the Tumor Microenvironment

Overview

Journal J Nanobiotechnology

Publisher Biomed Central

Specialty Biotechnology

Date 2022 May 3

PMID 35501802

Authors

Ying Li

Wenjing Zhao

Yanli Wang

Haiyan Wang

Shanglong Liu

Affiliations

Soon will be listed here.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) interacts closely with the tumor microenvironment (TME). The TME is remodeled by crosstalk between pancreatic cancer cells and stromal cells, and is critical for cancer progression. Extracellular vesicles (EVs), including exosomes and microvesicles, help facilitate an exchange of information both within the TME and to distant organs. EVs have also been identified as potential diagnostic biomarkers, therapeutic targets, and drug carriers for pancreatic cancer treatment. Thus, understanding the selective packaging of EVs cargo and its mechanistic impact will increase our understanding of cancer biology. In this review, we collect and analyze recent findings of the pancreatic cancer-stromal cell interactions mediated by EVs and the mechanisms involved in cancer-related immunity and chemoresistance. These studies demonstrate the vital role of EVs in pancreatic cancer reprogramming and TME remodeling. We also summarize the EVs identified as potential PDAC diagnostic biomarkers and possible therapeutic targets. This greater understanding is a promising avenue for transitioning EVs from bench to bedside.

Citing Articles

Prospect of extracellular vesicles in tumor immunotherapy.

Xia W, Tan Y, Liu Y, Xie N, Zhu H Front Immunol. 2025; 16:1525052.

PMID: 40078996 PMC: 11897508. DOI: 10.3389/fimmu.2025.1525052.

TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study.

Jiang A, Liu Y, He Z, Liu W, Yang Q, Fang Y J Natl Cancer Cent. 2024; 4(4):382-394.

PMID: 39735439 PMC: 11674438. DOI: 10.1016/j.jncc.2024.07.002.

Oncometabolites in pancreatic cancer: Strategies and its implications.

Maiti A, Mondal S, Choudhury S, Bandopadhyay A, Mukherjee S, Sikdar N World J Exp Med. 2024; 14(4):96005.

PMID: 39713078 PMC: 11551704. DOI: 10.5493/wjem.v14.i4.96005.

Potential clinical applications of extracellular vesicles in pancreatic cancer: exploring untapped opportunities from biomarkers to novel therapeutic approaches.

Sanchez-Manas J, Perez de Gracia N, Perales S, Martinez-Galan J, Torres C, Real P Extracell Vesicles Circ Nucl Acids. 2024; 5(2):180-200.

PMID: 39698536 PMC: 11648502. DOI: 10.20517/evcna.2023.68.

Exosome-delivered NR2F1-AS1 and NR2F1 drive phenotypic transition from dormancy to proliferation in treatment-resistant prostate cancer via stabilizing hormonal receptors.

Chen W, Mao Y, Zhan Y, Li W, Wu J, Mao X J Nanobiotechnology. 2024; 22(1):761.

PMID: 39695778 PMC: 11657369. DOI: 10.1186/s12951-024-03025-y.

References

Hernandez-Oller L, Seras-Franzoso J, Andrade F, Rafael D, Abasolo I, Gener P . Extracellular Vesicles as Drug Delivery Systems in Cancer. Pharmaceutics. 2020; 12(12). PMC: 7761384. DOI: 10.3390/pharmaceutics12121146. View

Liang K, Liu F, Fan J, Sun D, Liu C, Lyon C . Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples for Diagnosis and Treatment Monitoring. Nat Biomed Eng. 2017; 1. PMC: 5543996. DOI: 10.1038/s41551-016-0021. View

Emmanouilidi A, Paladin D, Greening D, Falasca M . Oncogenic and Non-Malignant Pancreatic Exosome Cargo Reveal Distinct Expression of Oncogenic and Prognostic Factors Involved in Tumor Invasion and Metastasis. Proteomics. 2019; 19(8):e1800158. DOI: 10.1002/pmic.201800158. View

Yang Q, Diamond M, Al-Hendy A . The emerging role of extracellular vesicle-derived miRNAs: implication in cancer progression and stem cell related diseases. J Clin Epigenet. 2016; 2(1). PMC: 4834835. View

Vasconcelos M, Caires H, Abols A, Xavier C, Line A . Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance. Drug Resist Updat. 2019; 47:100647. DOI: 10.1016/j.drup.2019.100647. View

Zhou W, Zhou Y, Chen X, Ning T, Chen H, Guo Q . Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials. 2020; 268:120546. DOI: 10.1016/j.biomaterials.2020.120546. View

Bruno S, Collino F, Deregibus M, Grange C, Tetta C, Camussi G . Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev. 2012; 22(5):758-71. DOI: 10.1089/scd.2012.0304. View

Chen J, Wang S, Jia S, Ding G, Jiang G, Cao L . Integrated Analysis of Long Non-Coding RNA and mRNA Expression Profile in Pancreatic Cancer Derived Exosomes Treated Dendritic Cells by Microarray Analysis. J Cancer. 2018; 9(1):21-31. PMC: 5743708. DOI: 10.7150/jca.21749. View

Xiao L, Erb U, Zhao K, Hackert T, Zoller M . Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer. Oncoimmunology. 2017; 6(6):e1319044. PMC: 5486185. DOI: 10.1080/2162402X.2017.1319044. View

10.

Shin H, Jung S, Park S, Dua P, Lee D . ALPPL2 Is a Potential Diagnostic Biomarker for Pancreatic Cancer-Derived Extracellular Vesicles. Mol Ther Methods Clin Dev. 2019; 15:204-210. PMC: 6819892. DOI: 10.1016/j.omtm.2019.08.016. View

11.

Pang W, Su J, Wang Y, Feng H, Dai X, Yuan Y . Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts. Cancer Sci. 2015; 106(10):1362-9. PMC: 4638007. DOI: 10.1111/cas.12747. View

12.

Lee H, Leem G, Kang H, Jo J, Chung M, Jang S . Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma. J Gastroenterol Hepatol. 2020; 36(2):516-522. DOI: 10.1111/jgh.15265. View

13.

Zonari E, Pucci F, Saini M, Mazzieri R, Politi L, Gentner B . A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. Blood. 2013; 122(2):243-52. DOI: 10.1182/blood-2012-08-449306. View

14.

Qin D, Zhao Y, Guo Q, Zhu S, Zhang S, Min L . Detection of Pancreatic Ductal Adenocarcinoma by A qPCR-based Normalizer-free Circulating Extracellular Vesicles RNA Signature. J Cancer. 2021; 12(5):1445-1454. PMC: 7847660. DOI: 10.7150/jca.50716. View

15.

Sousa C, Biancur D, Wang X, Halbrook C, Sherman M, Zhang L . Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. 2016; 536(7617):479-83. PMC: 5228623. DOI: 10.1038/nature19084. View

16.

Richards K, Zeleniak A, Fishel M, Wu J, Littlepage L, Hill R . Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene. 2016; 36(13):1770-1778. PMC: 5366272. DOI: 10.1038/onc.2016.353. View

17.

Ozdemir B, Pentcheva-Hoang T, Carstens J, Zheng X, Wu C, Simpson T . Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014; 25(6):719-34. PMC: 4180632. DOI: 10.1016/j.ccr.2014.04.005. View

18.

Haga H, Yan I, Takahashi K, Wood J, Zubair A, Patel T . Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth. J Extracell Vesicles. 2015; 4:24900. PMC: 4283029. DOI: 10.3402/jev.v4.24900. View

19.

Li J, Wu X, Schiffmann L, MacVicar T, Zhou C, Wang Z . IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth. Cancers (Basel). 2021; 13(21). PMC: 8611647. DOI: 10.3390/cancers13215338. View

20.

Ali S, Suresh R, Banerjee S, Bao B, Xu Z, Wilson J . Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells. Am J Cancer Res. 2015; 5(3):1251-64. PMC: 4449452. View